Docetaxel in Treating Women With Ovarian Epithelial or Primary Peritoneal Cancer
Status:
Completed
Trial end date:
2003-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of docetaxel in treating women who have
ovarian epithelial cancer or primary peritoneal cancer that has not responded to previous
treatment.